Mary C. Clouser

1.2k total citations
40 papers, 884 citations indexed

About

Mary C. Clouser is a scholar working on Emergency Medicine, Surgery and Reproductive Medicine. According to data from OpenAlex, Mary C. Clouser has authored 40 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Emergency Medicine, 8 papers in Surgery and 8 papers in Reproductive Medicine. Recurrent topics in Mary C. Clouser's work include Ovarian cancer diagnosis and treatment (8 papers), Trauma and Emergency Care Studies (6 papers) and Injury Epidemiology and Prevention (5 papers). Mary C. Clouser is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Trauma and Emergency Care Studies (6 papers) and Injury Epidemiology and Prevention (5 papers). Mary C. Clouser collaborates with scholars based in United States, Denmark and Austria. Mary C. Clouser's co-authors include David S. Alberts, Michael R. Galarneau, Denise J. Roe, Maurie Markman, Susan L. Eskridge, Sharon P. Wilczynski, Andrew J. MacGregor, Robin B. Harris, Janet A. Foote and Cameron T. McCabe and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mary C. Clouser

38 papers receiving 865 citations

Peers

Countries citing papers authored by Mary C. Clouser

Since Specialization

Citations

This map shows the geographic impact of Mary C. Clouser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary C. Clouser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary C. Clouser more than expected).

Fields of papers citing papers by Mary C. Clouser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary C. Clouser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary C. Clouser. The network helps show where Mary C. Clouser may publish in the future.

Co-authorship network of co-authors of Mary C. Clouser

This figure shows the co-authorship network connecting the top 25 collaborators of Mary C. Clouser. A scholar is included among the top collaborators of Mary C. Clouser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary C. Clouser. Mary C. Clouser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic literature review of MTAP deletions in solid and hematologic Cancers 2025 ·Cancer Treatment and Research Communications ·Mary C. Clouser, Mina Suh, Naimisha Movva, Janet S. Hildebrand, (unknown), (unknown), Antreas Hindoyan, Akhila Balasubramanian, Jon P. Fryzek, (unknown)	0
2	Risk and adverse clinical outcomes of thrombocytopenia among patients with solid tumors—a Danish population-based cohort study 2024 ·British Journal of Cancer ·Kasper Adelborg, Katalin Veres, Erzsébet Horváth–Puhó, Mary C. Clouser, (unknown), Henrik Toft Sørensen	2
3	Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway 2024 ·British Journal of Haematology ·Christian Fynbo Christiansen, (unknown), Waleed Ghanima, Marie Linder, Shahram Bahmanyar, (unknown), Mary C. Clouser, Mette Nørgaard, Henrik Toft Sørensen	0
4	Controlling for Differential Regression-To-The-Mean via Propensity Scores: A Simulation Study 2023 ·Clinical Epidemiology ·(unknown), Leah J. McGrath, Mary C. Clouser, Carrie M. Nielson, (unknown), Akhila Balasubramanian, Alexander Breskin, M. Alan Brookhart	1
5	Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention 2022 ·Pediatric Blood & Cancer ·(unknown), Katherine Armstrong, Audrey Mauguen, Emily K. Slotkin, Stephen S. Roberts, Ira J. Dunkel, Mary C. Clouser, Michael V. Ortiz, Gerald A. Soff	3
6	Low back pain, mental health symptoms, and quality of life among injured service members. 2020 ·Health Psychology ·(unknown), Cameron T. McCabe, (unknown), Shawn Farrokhi, (unknown), Mary C. Clouser, Michael R. Galarneau	26
7	Major deployment-related amputations of lower and upper limbs, active and reserve components, U.S. Armed Forces, 2001-2017. 2018 ·PubMed ·Shawn Farrokhi, (unknown), Susan L. Eskridge, Mary C. Clouser	31
8	Health-related quality of life among US military personnel injured in combat: findings from the Wounded Warrior Recovery Project 2018 ·Quality of Life Research ·Susan I. Woodruff, Michael R. Galarneau, Cameron T. McCabe, Daniel I. Sack, Mary C. Clouser	28
9	Impact of Blast Injury on Hearing in a Screened Male Military Population 2017 ·American Journal of Epidemiology ·(unknown), Jaime L. Shaw, Mary C. Clouser, Andrew J. MacGregor, Michael R. Galarneau	16
10	The Extremity Trauma and Amputation Center of Excellence: Overview of the Research and Surveillance Division 2016 ·Military Medicine ·Christopher A. Rábago, Mary C. Clouser, Christopher L. Dearth, Shawn Farrokhi, Michael R. Galarneau, M. Jason Highsmith, Jason M. Wilken, Marilynn Wyatt, Owen T. Hill	6
11	Effectiveness of the combat pelvic protection system in the prevention of genital and urinary tract injuries 2015 ·The Journal of Trauma: Injury, Infection, and Critical Care ·John S. Oh, Nhan Do, Mary C. Clouser, Michael R. Galarneau, (unknown), Adrian Katschke, Jon Clasper, Eric Kuncir	15
12	Dwell Time and Psychological Screening Outcomes Among Military Service Members With Multiple Combat Deployments 2014 ·Military Medicine ·Andrew J. MacGregor, (unknown), Mary C. Clouser, Peggy Han, Michael R. Galarneau	12
13	Co-occurring mental health and alcohol misuse: Dual disorder symptoms in combat injured veterans 2013 ·Addictive Behaviors ·(unknown), Mary C. Clouser, Andrew J. MacGregor, Sonya B. Norman, Michael R. Galarneau	24
14	Dose Response of Retinol and Isotretinoin in the Prevention of Nonmelanoma Skin Cancer Recurrence 2010 ·Nutrition and Cancer ·Mary C. Clouser, Denise J. Roe, Janet A. Foote, Robin B. Harris, David S. Alberts	13
15	Effect of non‐steroidal anti‐inflammatory drugs on non‐melanoma skin cancer incidence in the SKICAP‐AK trial 2009 ·Pharmacoepidemiology and Drug Safety ·Mary C. Clouser, Denise J. Roe, Janet A. Foote, Robin B. Harris	45
16	Biomarker Targets and Novel Therapeutics 2009 ·Cancer treatment and research ·Mary C. Clouser, Lisa M. Hess, Setsuko K. Chambers	3
17	Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival 2008 ·Gynecologic Oncology ·David S. Alberts, Christian Marth, Ronald D. Alvarez, Gary A. Johnson, Mariusz Bidziński, David Kardatzke, Williamson Z. Bradford, (unknown), David H. Kirn, Mary C. Clouser, Maurie Markman	98
18	Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200) 2007 ·Gynecologic Oncology ·David S. Alberts, Pengfei Liu, Sharon P. Wilczynski, Mary C. Clouser, Ana Mariá López, (unknown), Victor J. Lanzotti, Maurie Markman	94
19	Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211) 2007 ·International Journal of Gynecological Cancer ·David S. Alberts, (unknown), Sharon P. Wilczynski, (unknown), James Moon, (unknown), Joachim Beck, Mary C. Clouser, Maurie Markman	56
20	Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma Recurrence 2005 ·JNCI Journal of the National Cancer Institute ·David S. Alberts, Marı́a Elena Martı́nez, Lisa M. Hess, Janine G. Einspahr, Sylvan B. Green, A. K. Bhattacharyya, Jose Guillen, Mary F. Krutzsch, (unknown), Gerald Salen, (unknown), (unknown), D. J. Parish, Mary C. Clouser, Denise J. Roe, Peter Lance	190

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact